Showing results (141-150 of 155) with videos related to
Sort By:
Pageof 16
Psychopharmacology|April 26, 2022
Effects of modafinil on electroencephalographic microstates in healthy adultsSamantha R Linton, Michael Murphy, Hans S Schroder, et al.Journal of Medicinal Chemistry|July 2, 2016
Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic AnaloguesShashank Kulkarni, Spyros P Nikas, Rishi Sharma, et al.The British Journal of Psychiatry : the Journal of Mental Science|March 23, 2013
Group-based cognitive-behavioural anger management for people with mild to moderate intellectual disabilities: cluster randomised controlled trialPaul Willner, John Rose, Andrew Jahoda, et al.Molecules (Basel, Switzerland)|June 28, 2023
Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphansJoshua A Lutz, Agnieszka Sulima, Eugene S Gutman, et al.Molecules (Basel, Switzerland)|October 14, 2022
A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and AntagonistsDana R Chambers, Agnieszka Sulima, Dan Luo, et al.Journal of Cognitive Neuroscience|February 23, 2022
Error-related Alpha Suppression: Scalp Topography and (Lack of) Modulation by ModafinilHans S Schroder, Ann M Iturra-Mena, Micah Breiger, et al.Journal of Medicinal Chemistry|November 30, 2013
Controlled-deactivation cannabinergic ligandsRishi Sharma, Spyros P Nikas, Carol A Paronis, et al.Psychopharmacology|February 23, 2018
Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamineKathryn D Fischer, Alex C W Houston, Rajeev I Desai, et al.BMJ Open|December 17, 2025
A multicentred two-arm parallel single-blind superiority randomised controlled trial comparing psychological and emotional stabilisation with eye movement desensitisation and reprocessing and treatment-as-usual to treatment-as-usual with adults with intellectual disabilities who have post-traumatic stress disorder (the Trauma-AID trial): protocolPaul Willner, Pippa Anderson, Jonathan I Bisson, et al.Journal of Medicinal Chemistry|December 4, 2014
Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinolsSpyros P Nikas, Rishi Sharma, Carol A Paronis, et al.Pageof 16